Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text

First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer

Benjamin Solomon, Tony Mok, Dong‐Wan Kim et al. · New England Journal of Medicine · 2014 · 3.2K citations · Full text

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

Joanne Yu, Linda May, Vladimir Lhotak et al. · Blood · 2004 · 556 citations · Full text

Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

Margot Tesselaar, Fred P.H.T.M. Romijn, I K van der Linden et al. · Journal of Thrombosis and Haemostasis · 2007 · 530 citations · Full text

Thrombosis, Blood Platelet, Hematology +8

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

David S. Ettinger, Dara L. Aisner, Douglas E. Wood et al. · Journal of the National Comprehensive Cancer Network · 2018 · 465 citations · Full text